{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:16:21Z","timestamp":1793499381130,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11259-021-09869-1","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:03:39Z","timestamp":1641427419000},"page":"447-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intraperitoneal administration of synthetic microRNA-214 elicits tumor suppression in an intraperitoneal dissemination mouse model of canine hemangiosarcoma"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5272-4412","authenticated-orcid":false,"given":"Ryutaro","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Sawadaishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kohgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"9869_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/nejmoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA, Gynecologic Oncology Group (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34\u201343. https:\/\/doi.org\/10.1056\/nejmoa052985","journal-title":"N Engl J Med"},{"key":"9869_CR2","first-page":"56","volume":"186","author":"NO Brown","year":"1985","unstructured":"Brown NO, Patnaik AK, MacEwen EG (1985) Canine hemangiosarcoma: retrospective analysis of 104 cases. J Am Vet Med Assoc 186:56\u201358","journal-title":"J Am Vet Med Assoc"},{"key":"9869_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1892\/0891-6640(2004)18%3C330:mriofs%3E2.0.co;2","volume":"18","author":"CA Clifford","year":"2004","unstructured":"Clifford CA, Pretorius ES, Weisse C, Sorenmo KU, Drobatz KJ, Siegelman ES, Solomon JA (2004) Magnetic resonance imaging of focal splenic and hepatic lesions in the dog. J Vet Intern Med 18:330\u2013338. https:\/\/doi.org\/10.1892\/0891-6640(2004)18%3C330:mriofs%3E2.0.co;2","journal-title":"J Vet Intern Med"},{"key":"9869_CR4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704\u2013714. https:\/\/doi.org\/10.1038\/nrg2634","journal-title":"Nat Rev Genet"},{"key":"9869_CR5","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","volume":"133","author":"J Gerdes","year":"1984","unstructured":"Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710\u20131715","journal-title":"J Immunol"},{"key":"9869_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1939-1676.1991.tb00943.x","volume":"10","author":"AS Hammer","year":"1996","unstructured":"Hammer AS, Couto CG, Flippi J, Getzy D, Shank K (1996) Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Intern Med 10:379\u2013384. https:\/\/doi.org\/10.1111\/j.1939-1676.1991.tb00943.x","journal-title":"J Vet Intern Med"},{"key":"9869_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1021\/bc9005267","volume":"21","author":"K Hatanaka","year":"2010","unstructured":"Hatanaka K, Asai T, Koide H, Kenjo E, Tsuzuku T, Harada N, Tsukada H, Oku N (2010) Development of double-stranded siRNA labeling method using positron emitter and its in vivo trafficking analyzed by positron emission tomography. Bioconjug Chem 21:756\u2013763. https:\/\/doi.org\/10.1021\/bc9005267","journal-title":"Bioconjug Chem"},{"key":"9869_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137361","volume":"10","author":"K Heishima","year":"2015","unstructured":"Heishima K, Mori T, Sakai H, Sugito N, Murakami M, Yamada N, Akao Y, Maruo K (2015) MicroRNA-214 promotes apoptosis in canine hemangiosarcoma by targeting the COP1-p53 axis. PLoS ONE 10:e0137361. https:\/\/doi.org\/10.1371\/journal.pone.0137361","journal-title":"PLoS ONE"},{"key":"9869_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"9869_CR10","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1016\/j.bmc.2018.08.001","volume":"26","author":"T Kano","year":"2018","unstructured":"Kano T, Katsuragi Y, Maeda Y, Ueno Y (2018) Synthesis and properties of 4\u2032-C-aminoalkyl-2\u2032-fluoro-modified RNA T oligomers. Bioorg Med Chem 26:4574\u20134582. https:\/\/doi.org\/10.1016\/j.bmc.2018.08.001","journal-title":"Bioorg Med Chem"},{"key":"9869_CR11","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1292\/jvms.15-0262","volume":"77","author":"M Kim","year":"2015","unstructured":"Kim M, Choi S, Choi H, Lee Y, Lee K (2015) Diagnosis of a large splenic tumor in a dog: computed tomography versus magnetic resonance imaging. J Vet Med Sci 77:1685\u20131687. https:\/\/doi.org\/10.1292\/jvms.15-0262","journal-title":"J Vet Med Sci"},{"key":"9869_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1740-8261.1999.tb00890.x","volume":"40","author":"H Kippenes","year":"1999","unstructured":"Kippenes H, Gavin PR, Bagley RS, Silver GM, Tucker RL, Sande RD (1999) Magnetic resonance imaging features of tumors of the spine and spinal cord in dogs. Vet Radiol Ultrasound 40:627\u2013633. https:\/\/doi.org\/10.1111\/j.1740-8261.1999.tb00890.x","journal-title":"Vet Radiol Ultrasound"},{"key":"9869_CR14","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1016\/j.bmc.2018.05.025","volume":"26","author":"K Koizumi","year":"2018","unstructured":"Koizumi K, Maeda Y, Kano T, Yoshida H, Sakamoto T, Yamagishi K, Ueno Y (2018) Synthesis of 4\u2032-C-aminoalkyl-2\u2032-O-methyl modified RNA and their biological T properties. Bioorg Med Chem 26:3521\u20133534. https:\/\/doi.org\/10.1016\/j.bmc.2018.05.025","journal-title":"Bioorg Med Chem"},{"key":"9869_CR16","doi-asserted-by":"publisher","unstructured":"Miwa T, Kanda M, Umeda S, Tanaka H, Shimizu D, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y (2019) Establishment of peritoneal and hepatic metastasis mouse xenograft models using gastric cancer cell lines. In Vivo 33:1785\u20131792. https:\/\/doi.org\/10.21873\/invivo.11669","DOI":"10.21873\/invivo.11669"},{"key":"9869_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1939-1676.1991.tb00953.x","volume":"5","author":"AS Moore","year":"1991","unstructured":"Moore AS, Kirk C, Cardona A (1991) Intracavitary cisplatin chemotherapy experience with six dogs. J Vet Intern Med 5:227\u2013231. https:\/\/doi.org\/10.1111\/j.1939-1676.1991.tb00953.x","journal-title":"J Vet Intern Med"},{"key":"9869_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1746-6148-8-128","volume":"8","author":"A Murai","year":"2012","unstructured":"Murai A, Asa SA, Kodama A, Hirata A, Yanai T, Sakai H (2012) Constitutive phosphorylation of the mTORC2\/Akt\/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines. BMC Vet Res 8:128. https:\/\/doi.org\/10.1186\/1746-6148-8-128","journal-title":"BMC Vet Res"},{"key":"9869_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1939-1676.1994.tb03211.x","volume":"8","author":"J Olsen","year":"1994","unstructured":"Olsen J, Komtebedde J, Lackner A, Madewell BR (1994) Cytoreductive treatment of ovarian carcinoma in a dog. J Vet Intern Med 8:133\u2013135. https:\/\/doi.org\/10.1111\/j.1939-1676.1994.tb03211.x","journal-title":"J Vet Intern Med"},{"key":"9869_CR21","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1021\/acs.molpharmaceut.7b00789","volume":"15","author":"AM Prantner","year":"2018","unstructured":"Prantner AM, Yin C, Kamat K, Sharma K, Lowenthal AC, Madrid PB, Scholler N (2018) Molecular imaging of mesothelin-expressing ovarian cancer with a human and mouse cross-reactive nanobody. Mol Pharm 15:1403\u20131411. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00789","journal-title":"Mol Pharm"},{"key":"9869_CR22","first-page":"1055","volume":"65","author":"RG Pretorius","year":"1981","unstructured":"Pretorius RG, Petrilli ES, Kean CK, Ford LC, Hoeschele JD, Lagasse LD (1981) Comparison of the iv and ip routes of administration of cisplatin in dogs. Cancer Treatment Rep 65:1055\u20131062","journal-title":"Cancer Treatment Rep"},{"key":"9869_CR23","first-page":"706","volume":"193","author":"C Prymak","year":"1998","unstructured":"Prymak C, McKee LJ, Goldschmidt MH, Glickman LT (1998) Epidemiologic clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J Am Vet Med Assoc 193:706\u2013712","journal-title":"J Am Vet Med Assoc"},{"key":"9869_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2217\/fon.14.193","volume":"11","author":"T Sharma","year":"2015","unstructured":"Sharma T, Hamilton R, Mandal CC (2015) miR-214: A potential biomarker and therapeutic for different cancers. Future Oncol 11:349\u2013363. https:\/\/doi.org\/10.2217\/fon.14.193","journal-title":"Future Oncol"},{"key":"9869_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1939-1676.1993.tb01033.x","volume":"7","author":"KU Sorenmo","year":"1993","unstructured":"Sorenmo KU, Jeglum KA, Helfand SC (1993) Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide. J Vet Intern Med 7:370\u2013376. https:\/\/doi.org\/10.1111\/j.1939-1676.1993.tb01033.x","journal-title":"J Vet Intern Med"},{"key":"9869_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1892\/0891-6640(2004)18%3C209:eatoad%3E2.0.co;2","volume":"18","author":"KU Sorenmo","year":"2004","unstructured":"Sorenmo KU, Baez JL, Clifford CA, Mauldin E, Overley B, Skorupski K, Bachman R, Samluk M, Shofer F (2004) Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma. J Vet Intern Med 18:209\u2013213. https:\/\/doi.org\/10.1892\/0891-6640(2004)18%3C209:eatoad%3E2.0.co;2","journal-title":"J Vet Intern Med"},{"key":"9869_CR27","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/cvr\/cvs003","volume":"93","author":"A Van Mil","year":"2012","unstructured":"Van Mil A, Grundmann S, Goumans MJ, Lei Z, Oerlemans MI, Jaksani S, Doevendans PA, Sluijter JPG (2012) MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release. Cardiovasc Res 93:655\u2013665. https:\/\/doi.org\/10.1093\/cvr\/cvs003","journal-title":"Cardiovasc Res"},{"key":"9869_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/vco.12580","volume":"18","author":"R Yoshikawa","year":"2020","unstructured":"Yoshikawa R, Heishima K, Ueno Y, Kawade M, Maeda Y, Yoshida K, Murakami M, Sakai H, Akao Y, Mori T (2020) Development of synthetic microRNA-214 showing enhanced cytotoxicity and RNase resistance for treatment of canine hemangiosarcoma. Vet Comp Oncol 18:570\u2013579. https:\/\/doi.org\/10.1111\/vco.12580","journal-title":"Vet Comp Oncol"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-021-09869-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11259-021-09869-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-021-09869-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T00:49:22Z","timestamp":1674348562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11259-021-09869-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["9869"],"URL":"https:\/\/doi.org\/10.1007\/s11259-021-09869-1","relation":{},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"value":"0165-7380","type":"print"},{"value":"1573-7446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"7 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of animal experiments was reviewed and approved by the Ethics Review Board of the Joint Faculty of Veterinary Medicine of Gifu University (approval number: 2019\u2013117).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate (include appropriate statements)"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication (include appropriate statements)"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}